相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ex vivo and in vitro inhibitory potential of Kava extract on monoamine oxidase B activity in mice
Barbara Nunes Krum et al.
JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE (2022)
Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study
Jerome Sarris et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2020)
Glutamate Systems in DSM-5 Anxiety Disorders: Their Role and a Review of Glutamate and GABA Psychopharmacology
Madeeha Nasir et al.
FRONTIERS IN PSYCHIATRY (2020)
Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis
April Slee et al.
LANCET (2019)
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori et al.
PHARMACOLOGY & THERAPEUTICS (2019)
GABA-modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence
Karen Savage et al.
PHYTOTHERAPY RESEARCH (2018)
Short communication: Sex-linked differences in gamma-aminobutyric acid (GABA) are related to social functioning in autism spectrum disorder
Melissa Kirkovski et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2018)
Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition
Borwin Bandelow et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2017)
GABA Concentrations in the Anterior Cingulate Cortex Are Associated with Fear Network Function and Fear Recovery in Humans
Nina Levar et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2017)
Big GABA: Edited MR spectroscopy at 24 research sites
Mark Mikkelsen et al.
NEUROIMAGE (2017)
The new field of 'precision psychiatry'
Brisa S. Fernandes et al.
BMC MEDICINE (2017)
Developing a clinical translational neuroscience taxonomy for anxiety and mood disorder: protocol for the baseline-follow up Research domain criteria Anxiety and Depression (RAD) project
Leanne M. Williams et al.
BMC PSYCHIATRY (2016)
Brain GABA Levels Across Psychiatric Disorders: A Systematic Literature Review and Meta-Analysis of 1H-MRS Studies
Remmelt R. Schur et al.
HUMAN BRAIN MAPPING (2016)
Neurobiological markers predicting treatment response in anxiety disorders: A systematic review and implications for clinical application
Ulrike Lueken et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Quantification of -aminobutyric acid (GABA) in 1H MRS volumes composed heterogeneously of grey and white matter
Mark Mikkelsen et al.
NMR IN BIOMEDICINE (2016)
Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism
Han Chow Chua et al.
PLOS ONE (2016)
Generalized anxiety disorder: psychopharmacotherapy update on a common and commonly overlooked condition
Vladan Starcevic
AUSTRALASIAN PSYCHIATRY (2015)
Emerging drugs for the treatment of anxiety
James W. Murrough et al.
EXPERT OPINION ON EMERGING DRUGS (2015)
Tissue correction for GABA-edited MRS: Considerations of voxel composition, tissue segmentation, and tissue relaxations
Ashley D. Harris et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2015)
Neuroprotective properties of kavalactones
Yew-Min Tzeng et al.
NEURAL REGENERATION RESEARCH (2015)
Generalized Anxiety Disorder
Murray B. Stein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial
Karen M. Savage et al.
TRIALS (2015)
The NIMH Research Domain Criteria (RDoC) Project: Precision Medicine for Psychiatry
Thomas R. Insel
AMERICAN JOURNAL OF PSYCHIATRY (2014)
INSULA AND ANTERIOR CINGULATE GABA LEVELS IN POSTTRAUMATIC STRESS DISORDER: PRELIMINARY FINDINGS USING MAGNETIC RESONANCE SPECTROSCOPY
Isabelle M. Rosso et al.
DEPRESSION AND ANXIETY (2014)
Gannet: A Batch-Processing Tool for the Quantitative Analysis of Gamma-Aminobutyric Acid-Edited MR Spectroscopy Spectra
Richard A. E. Edden et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2014)
A Guide to the Metabolic Pathways and Function of Metabolites Observed in Human Brain H-1 Magnetic Resonance Spectra
Caroline D. Rae
NEUROCHEMICAL RESEARCH (2014)
Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA
Paul G. Mullins et al.
NEUROIMAGE (2014)
Measurement of regional variation of GABA in the human brain by optimized point-resolved spectroscopy at 7 T in vivo
Sandeep K. Ganji et al.
NMR IN BIOMEDICINE (2014)
A preliminary examination of cortical neurotransmitter levels associated with heavy drinking in posttraumatic stress disorder
David Louis Pennington et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2014)
Prefrontal GABA and glutathione imbalance in posttraumatic stress disorder: Preliminary findings
Lars Michels et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2014)
Development of a theoretically-derived human anxiety syndrome biomarker
Neil McNaughton
TRANSLATIONAL NEUROSCIENCE (2014)
Psychological treatment of generalized anxiety disorder: A meta-analysis
Pim Cuijpers et al.
CLINICAL PSYCHOLOGY REVIEW (2014)
The Initial Field Trials of DSM-5: New Blooms and Old Thorns
Robert Freedman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Toward the future of psychiatric diagnosis: the seven pillars of RDoC
Bruce N. Cuthbert et al.
BMC MEDICINE (2013)
Plant-Based Medicines for Anxiety Disorders, Part 1 A Review of Preclinical Studies
Jerome Sarris et al.
CNS DRUGS (2013)
A pilot study of hippocampal volume and N-acetylaspartate (NAA) as response biomarkers in riluzole-treated patients with GAD
Chadi G. Abdallah et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?
S. Kapur et al.
MOLECULAR PSYCHIATRY (2012)
In vivo magnetic resonance spectroscopy of GABA: A methodological review
Nicolaas A. J. Puts et al.
PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY (2012)
Pharmacological treatment of anxiety disorders: Current treatments and future directions
Frank J. Farach et al.
JOURNAL OF ANXIETY DISORDERS (2012)
Kava: a comprehensive review of efficacy, safety, and psychopharmacology
Jerome Sarris et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2011)
Neurocognitive effects of kava (Piper methysticum): a systematic review
E. LaPorte et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2011)
Evidence-based pharmacological treatment of generalized anxiety disorder
David S. Baldwin et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
ALTERED GABA TRANSMISSION IN A MOUSE MODEL OF INCREASED TRAIT ANXIETY
R. O. Tasan et al.
NEUROSCIENCE (2011)
Emotional processing in anterior cingulate and medial prefrontal cortex
Amit Etkin et al.
TRENDS IN COGNITIVE SCIENCES (2011)
A pilot study of the effects of chronic paroxetine administration on hippocampal N-acetylaspartate in generalized anxiety disorder
S. J. Mathew et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
The Neurocircuitry of Fear, Stress, and Anxiety Disorders
Lisa M. Shin et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Behavioral and Neural Analysis of GABA in the Acquisition, Consolidation, Reconsolidation, and Extinction of Fear Memory
Steve R. Makkar et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Is Pharma Running Out of Brainy Ideas?
Greg Miller
SCIENCE (2010)
Developing Constructs for Psychopathology Research: Research Domain Criteria
Charles A. Sanislow et al.
JOURNAL OF ABNORMAL PSYCHOLOGY (2010)
Dissemination of cognitive-behavioral treatments for anxiety disorders: Overcoming barriers and improving patient access
Raymond W. Gunter et al.
CLINICAL PSYCHOLOGY REVIEW (2010)
Prefrontal Cortical Gamma-Aminobutyric Acid Levels in Panic Disorder Determined by Proton Magnetic Resonance Spectroscopy
Gregor Hasler et al.
BIOLOGICAL PSYCHIATRY (2009)
Kava Anxiety Depression Spectrum Study (KADSS): A mixed methods RCT using an aqueous extract of Piper methysticum
J. Sarris et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2009)
Overview of Generalized Anxiety Disorder: Epidemiology, Presentation, and Course
Risa B. Weisberg
JOURNAL OF CLINICAL PSYCHIATRY (2009)
The brain's default network - Anatomy, function, and relevance to disease
Randy L. Buckner et al.
YEAR IN COGNITIVE NEUROSCIENCE 2008 (2008)
Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder
Sanjay J. Mathew et al.
BIOLOGICAL PSYCHIATRY (2008)
Anxiety disorders: A comprehensive review of pharmacotherapies
Ellen J. Hoffman et al.
MOUNT SINAI JOURNAL OF MEDICINE (2008)
High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: Response to treatment with levetiracetam
Mark H. Pollack et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
GABA concentrations in the human anterior cingulate cortex predict negative BOLD responses in fMRI
Georg Northoff et al.
NATURE NEUROSCIENCE (2007)
Functional neuroimaging of anxiety: A meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia
Amit Etkin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
Franz Faul et al.
BEHAVIOR RESEARCH METHODS (2007)
Decreased GABA levels in anterior cingulate and basal ganglia in medicated subjects with panic disorder:: A proton magnetic resonance spectroscopy (1H-MRS) study
Byung-Joo Ham et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Resting anterior cingulate activity and abnormal responses to errors in subjects with elevated depressive symptoms: A 128-channel EEG study
DA Pizzagalli et al.
HUMAN BRAIN MAPPING (2006)
Pain and emotion interactions in subregions of the cingulate gyrus
BA Vogt
NATURE REVIEWS NEUROSCIENCE (2005)
Naturopathic and Western herbal medicine practice in Australia - a workforce survey
A Bensoussan et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2004)
Extinction learning in humans: Role of the amygdala and vmPFC
EA Phelps et al.
NEURON (2004)
Longitudinal trajectories of depression and anxiety in a prospective community study - The Zurich cohort study
KR Merikangas et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Human cingulate cortex and autonomic control: converging neuroimaging and clinical evidence
HD Critchley et al.
BRAIN (2003)
Kavalactones and dihydrokavain modulate GABAergic activity in a rat gastric-brainstem preparation
CS Yuan et al.
PLANTA MEDICA (2002)
Generalized anxiety disorder: comorbidity, comparative biology and treatment
DJ Nutt et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2002)
Characterization of commercial kava-kava herbal drug and herbal drug preparations by means of nuclear magnetic resonance spectroscopy
AR Bilia et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2002)
Therapeutic potential of kava in the treatment of anxiety disorders
YN Singh et al.
CNS DRUGS (2002)
A systematic review of the safety of kava extract in the treatment of anxiety
C Stevinson et al.
DRUG SAFETY (2002)
New insights into the role of the GABAA-benzodiazepine receptor in psychiatric disorder
DJ Nutt et al.
BRITISH JOURNAL OF PSYCHIATRY (2001)
Automatic quantitation of localized in vivo 1H spectra with LCModel
SW Provencher
NMR IN BIOMEDICINE (2001)
Reductions in occipital cortex GABA levels in panic disorder detected with 1H-magnetic resonance spectroscopy
AW Goddard et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Comorbidity in generalized anxiety disorder
R Noyes
PSYCHIATRIC CLINICS OF NORTH AMERICA (2001)
A default mode of brain function
ME Raichle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Cognitive and emotional influences in anterior cingulate cortex
G Bush et al.
TRENDS IN COGNITIVE SCIENCES (2000)
Efficacy of kava extract for treating anxiety: Systematic review and meta-analysis
MH Pittler et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)
分享论文
